- pramiracetam sulfate
-
- $10.00 / 10g/Bag
-
2021-12-15
- CAS:72869-16-0
- Min. Order: 10g
- Purity: 99
- Supply Ability: 100KG
- PRAMIRACETAM SULFATE
-
- $6.00 / 1KG
-
2020-03-10
- CAS:72869-16-0
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1kg, 10kg ,50kg
|
| PRAMIRACETAM SULFATE Basic information |
Product Name: | PRAMIRACETAM SULFATE | Synonyms: | PRAMIRACETAM SULFATE;N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide sulfate;Pramiracetam sulphate;Amacetam sulfate;CI-879;1-PyrrolidineacetaMide, N-(2-(bis(1-Methylethyl)aMino)ethyl)-2-oxo-;N-[2-(Diisopropylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide;N-(2-(Diisopropylamino)ethyl)-2-(2-oxopyrrolidin-1-yl)acetamide sulfate | CAS: | 72869-16-0 | MF: | C14H27N3O2.H2O4S | MW: | 367.464 | EINECS: | 615-895-9 | Product Categories: | Health supplements;APIS;Brain health drug;Nootropic | Mol File: | 72869-16-0.mol | |
| PRAMIRACETAM SULFATE Chemical Properties |
Toxicity | LD50 in male, female mice (mg/kg): 5434, 4355 orally (Poschel) |
| PRAMIRACETAM SULFATE Usage And Synthesis |
Description | Pramiracetam sulfate, together with aniracetam are two nootropics of the piracetam
family introduced in 1993 for the treatment of attention and memory disorders resulting from
degenerative or vascular disorders in the elderly. In patients with mild to moderate primary
degenerative dementia, treatment with 75-300 mg/day of pramiracetam reduced depression,anxiety, sleep disturbance, and hostility with no observable adverse reactions. Significant
improvement of performance on measures of memory, especially delayed recall, have been
observed for pramiracetam treated patients with brain injury. | Originator | Warner-Lambert (U.S.A.) | Uses | Pramiracetam Sulfate is a nootropic and a cognition activator drug. It also increases the rate of learning of complex visual discrimination problems in young, normal rhesus monkeys. | Uses | Cognition adjuvant. | Brand name | Remen; Neupramir;
Prarnistar |
| PRAMIRACETAM SULFATE Preparation Products And Raw materials |
|